Verproside may be a good therapeutic candidate as an anti-asthma drug, blocking the tumor necrosis factor alpha (TNF-α)/nuclear factor kappa B (NF-κB) signaling pathway and reducing the levels of total immunoglobulin E, interleukin-4, and interleukin-13 [10,11]. The gene discussed is TNF; the disease is asthma.